4//SEC Filing
Rowland Thomas Andrew 4
Accession 0001507496-25-000002
CIK 0001023024other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:19 PM ET
Size
8.7 KB
Accession
0001507496-25-000002
Insider Transaction Report
Form 4
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Transactions
- Award
Common Stock
2025-02-12+7,834→ 41,452 total - Award
Common Stock
2025-02-12+5,222→ 46,674 total - Tax Payment
Common Stock
2025-02-14$58.92/sh−582$34,291→ 46,092 total
Footnotes (4)
- [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
- [F2]Includes 449 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).
- [F3]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
- [F4]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001507496
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:19 PM ET
- Size
- 8.7 KB